Vol. 11: Iss. 1, 2010

Faculty Masthead

Student Masthead

Introduction: MJLST at 5 Years, the Consortium at 10

Why Neuroscience Matters for Rational Drug Policy

Blaming the Brain

Imaging Genetics for Our Neurogenetic Future

Advancing Research on Stored Biological Materials: Reconciling Law, Ethics, and Practice

Gene Concepts, Gene Talk, and Gene Patents

Health Care Reform and the Logic of Emergence

Open Source Drug Development: A Path to More Accessible Drugs and Diagnostics?

Why the Fair Use Defense of Free Speech or Parody Under the Anticybersquatting Consumer Protection Act Needs Judicial Review by the United States Supreme Court

Sea Change or Status Quo: Has the Rule 37(e) Safe Harbor Advanced Best Practices for Records Management?

Integrating Social and Ethical Concerns Into Regulatory Decision-Making for Emerging Technologies

A Burkean Perspective on Patent Eligibility, Part II: Reflections on the (Counter)Revolution in Patent Law

The O'Neill Institute for National and Global Health Law: Discovering Innovative Solutions for the Most Pressing Health Problems Facing the Nation and the World

Preparation to Infringe after Medimmune v. Genentech: Why the Federal Circuit's Declaratory Judgment Jurisdiction Test is Still Too Stringent

Who is John Doe and Why Do We Care? Why a Uniform Approach to Dealing with John Doe Defamation Cases is Needed

Quanta and Patent Exhaustion: The Implications of the Supreme Court's Decision in Quanta Computer, Inc. v. LG Electronics, Inc. One Year Later